← Evidence map

ReviewFrontiers in immunology2026

Mapping benefit, risk, and opportunity in PAD4 inhibition.

Caio Santos Bonilha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41836413